Advertisement

Topics

Prurigo nodularis and pembrolizumab: A therapeutic challenge.

07:00 EST 5th February 2019 | BioPortfolio

Summary of "Prurigo nodularis and pembrolizumab: A therapeutic challenge."

No Summary Available

Affiliation

Journal Details

This article was published in the following journal.

Name: European journal of cancer (Oxford, England : 1990)
ISSN: 1879-0852
Pages: 8-10

Links

DeepDyve research library

PubMed Articles [8887 Associated PubMed Articles listed on BioPortfolio]

Dramatic improvement of generalized prurigo nodularis with dupilumab.

Prurigo nodularis (PN) is a common and debilitating skin condition with an unmet therapeutic need since there are no currently approved therapies and off-label treatments have limited efficacy. We des...

A Systematic Review of Evidence-Based Treatments for Prurigo Nodularis.

Prurigo nodularis is a chronic dermatologic condition involving the development of multiple cutaneous nodules in the setting of intractable pruritus. Given emerging treatment options for this difficul...

Dupilumab Treatment for Generalized Prurigo Nodularis.

Reduced Itch Associated With Dupilumab Treatment In 4 Patients With Prurigo Nodularis.

Association between prurigo nodularis and malignancy in middle-aged adults.

Clinical Trials [3911 Associated Clinical Trials listed on BioPortfolio]

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Prurigo Nodularis

Study of the efficacy, safety, tolerability, pharmacokinetics (PK) and immunogenicity of KPL-716 in subjects with prurigo nodularis.

Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis

Prurigo nodularis (PN) is a common dermatological disorder, manifested as scaly nodules which appear mainly on the extensor surfaces of the limbs. PN may appear secondarily to skin scratch...

Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis

This study will evaluate the anti-pruritic effect of apremilast in patients with known PN.

Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease

The development of the topical calcineurin inhibitor pimecrolimus resulted in a significant improvement in the treatment of atopic dermatitis. In addition, an excellent amelioration of pru...

PRISM Study-Pruritus Relief Through Itch Scratch Modulation

To investigate the anti-pruritic efficacy and safety of Nalbuphine ER (NAL ER) tablets in Prurigo Nodularis. Subjects will be randomized to NAL ER (or matching placebo) with the primary en...

Medical and Biotech [MESH] Definitions

A name applied to several itchy skin eruptions of unknown cause. The characteristic course is the formation of a dome-shaped papule with a small transient vesicle on top, followed by crusting over or lichenification. (From Dorland, 27th ed)

The organization, management, and assumption of risks of a business or enterprise, usually implying an element of change or challenge and a new opportunity.

Undertaking a task involving a challenge for achievement or a desirable goal in which there is a lack of certainty or a fear of failure. It may also include the exhibiting of certain behaviors whose outcomes may present a risk to the individual or to those associated with him or her.

Expectation of real uncertainty on the part of the investigator regarding the comparative therapeutic merits of each arm in a trial.

A frequent complication of drug therapy for microbial infection. It may result from opportunistic colonization following immunosuppression by the primary pathogen and can be influenced by the time interval between infections, microbial physiology, or host resistance. Experimental challenge and in vitro models are sometimes used in virulence and infectivity studies.

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Searches Linking to this Article